Viewing Study NCT00391846



Ignite Creation Date: 2024-05-05 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00391846
Status: COMPLETED
Last Update Posted: 2012-06-25
First Post: 2006-10-19

Brief Title: Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide NTproBNP vs Clinical Symptoms and Signs Alone
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: A Randomised Single Blind Multicentre 9-month Phase IV Study Comparing Treatment Guided by Clinical Symptoms and Signs and NT-proBNP vs Treatment Guided by Clinical Symptoms and Signs Alone in Patients With Heart Failure HF and Left Ventricular Systolic Dysfunction
Status: COMPLETED
Status Verified Date: 2012-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose is to study if HF treatment guided by NTproBNP in addition to clinical symptoms and signs is more effective than treatment guided by clinical symptoms and signs alone in patients with HF and left ventricular systolic dysfunction
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
SIGNAL HF None None None
EUDRACT No 2006-001259-36 None None None